Growing evidence indicates that innate and adaptive immune cells could release inflammatory mediators such as cytokines, chemokines, growth factors and proteolytic enzymes, as well as activate transcription factors (NF-κB, STAT3, etc.), contributing to tumor progression when present in the TME [30]. The gene discussed is NFKB1; the disease is neoplasm.